HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Kammertoens Selected Research

Salts

1/2019High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Kammertoens Research Topics

Disease

23Neoplasms (Cancer)
10/2022 - 07/2003
2Necrosis
01/2020 - 01/2011
2Carcinogenesis
12/2013 - 10/2012
2Lymphoma (Lymphomas)
01/2013 - 01/2012
2Inflammation (Inflammations)
09/2009 - 11/2007
1Neoplasm Metastasis (Metastasis)
10/2022
1Lymphatic Vessel Tumors
10/2022
1Wasting Syndrome (Wasting Disease)
01/2020
1Autoimmune Diseases (Autoimmune Disease)
01/2020
1Lymphopenia (Lymphocytopenia)
01/2019
1Melanoma (Melanoma, Malignant)
03/2016
1Papilloma (Papillomatosis)
12/2013
1Fibrosarcoma
05/2013
1Foreign-Body Reaction
05/2013
1Carcinoma (Carcinomatosis)
05/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2012
1Plasmacytoma
01/2011
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2010
1Leukemia
03/2010
1Rheumatoid Arthritis
09/2009
1Body Weight (Weight, Body)
09/2009
1Asthma (Bronchial Asthma)
11/2007
1Adenoviridae Infections (Adenovirus Infections)
06/2005
1Infarction (Infarctions)
05/2005
1Residual Neoplasm
05/2005
1Hematologic Neoplasms (Hematological Malignancy)
08/2004
1Graft vs Host Disease (Graft-Versus-Host Disease)
08/2004
1Breast Neoplasms (Breast Cancer)
03/2004

Drug/Important Bio-Agent (IBA)

8AntigensIBA
10/2022 - 08/2004
6CytokinesIBA
01/2020 - 03/2004
3Neoplasm Antigens (Tumor Antigens)IBA
10/2022 - 09/2009
3InterferonsIBA
10/2022 - 01/2012
3Interleukin-4 (Interleukin 4)IBA
12/2013 - 03/2004
3MethylcholanthreneIBA
12/2013 - 10/2012
3PerforinIBA
02/2013 - 07/2003
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2020 - 03/2016
2Fas Ligand Protein (Fas Ligand)IBA
02/2013 - 10/2012
2Proteins (Proteins, Gene)FDA Link
01/2012 - 06/2005
2Interferon-gamma (Interferon, gamma)IBA
01/2011 - 07/2003
2AutoantigensIBA
09/2009 - 06/2005
2AntibodiesIBA
06/2005 - 03/2004
1LipopolysaccharidesIBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1Cytokine Receptors (Cytokine Receptor)IBA
01/2020
1Blocking AntibodiesIBA
01/2020
1A-factor (Streptomyces)IBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
01/2019
1SaltsIBA
01/2019
1Cyclin-Dependent Kinase 4IBA
03/2016
1EpitopesIBA
03/2016
1MART-1 AntigenIBA
03/2016
1Interleukin-13IBA
12/2013
1anthraceneIBA
12/2013
1Acetates (Acetic Acid Esters)FDA Link
12/2013
1CarcinogensIBA
05/2013
1Ganciclovir (Cytovene)FDA LinkGeneric
05/2013
1S100 Calcium-Binding Protein A4IBA
05/2013
1CollagenIBA
05/2013
1Capsules (Microcapsules)IBA
05/2013
1Collagenases (Collagenase)FDA Link
05/2013
1Peptides (Polypeptides)IBA
04/2013
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2013
1OvalbuminIBA
01/2012
1Pharmaceutical PreparationsIBA
12/2011
1SuspensionsIBA
01/2011
1Doxycycline (Periostat)FDA LinkGeneric
01/2011
1Immunoglobulins (Immunoglobulin)IBA
03/2010
1staphylococcal enterotoxin BIBA
09/2009
1GlucocorticoidsIBA
09/2009
1Nerve Growth Factors (Neurotrophins)IBA
11/2007
1Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
11/2007
1Interleukin-2 (IL2)IBA
08/2007
1VimentinIBA
06/2005
1Complementary DNA (cDNA)IBA
06/2005
1alpha Catenin (alpha E-Catenin)IBA
06/2005
1Immunoglobulin G (IgG)IBA
06/2005
1Green Fluorescent ProteinsIBA
04/2005
1Lymphotoxin-alpha (Lymphotoxin)IBA
04/2004
1DNA VaccinesIBA
03/2004

Therapy/Procedure

6Immunotherapy
10/2022 - 05/2005
6Therapeutics
01/2020 - 11/2007
2Transplantation
01/2019 - 08/2004
1Subcutaneous Injections
05/2013
1Drug Therapy (Chemotherapy)
03/2010
1Homologous Transplantation
08/2004
1Hematopoietic Stem Cell Transplantation
08/2004